Boehringer Ingelheim Biopharmaceuticals announces manufacturing agreement with Servier
3 August 2012 | By Boehringer Ingelheim
Boehringer Ingelheim announced an agreement with Servier & its partner XOMA Corporation...
List view / Grid view
News
Regulatory Update – GSK announces submissions in the EU and US for dabrafenib and trametinib
3 August 2012 | By GlaxoSmithKline
GlaxoSmithKline announced regulatory submissions in the European Union and US...
Lonza announces license agreement with iPS Academia Japan
Lonza has entered a worldwide, non-exclusive licensing agreement with iPS Academia Japan, Inc. for its induced pluripotent stem cell (iPSC) patent portfolio. By entering this agreement, Lonza demonstrates its commitment to the field of regenerative medicine and reinforces its belief that iPSCs are a key platform technology for the cell…
Teva Pharmaceutical announces new appointments
2 August 2012 | By Teva Pharmaceutical Industries Ltd
Dr. Carlo De Notaristefani appointed as President and CEO of Global Operations, and Mr. Aharon (Arik) Yaari as the Executive VP...
Gilead Sciences announces new collaboration with Indian partners
2 August 2012 | By Gilead Sciences, Inc.
Gilead Sciences, Inc., together with Mylan Laboratories, Ranbaxy Laboratories Limited and Strides Arcolab, have entered into agreements...
Bristol-Myers Squibb suspends administration of study drug in Clinical Trial of investigational NS5B nucleotide for the treatment of Hepatitis C
1 August 2012 | By Bristol-Myers Squibb Company
Administration of study drug suspended...
Pfizer announces positive top-line results from the ORAL Start Phase 3 study of Tofacitinib in RA
31 July 2012 | By Pfizer
Pfizer also provides update on Tofacitinib filing in the U.S.
Pluristem’s PLX Cells show efficacy in treating lung disease
31 July 2012 | By FINN PARTNERS
Statistically significant animal model results indicate PLX cells could improve the lives of people with interstitial lung disease...
FOSS NIRSystems introduces the NIRS DS2500 analyzer
31 July 2012 | By FOSS NIRSystems Inc
FOSS NIRSystems is pleased to announce the introduction of the FOSS NIRS™ DS2500 analyzer...
Lilly supports research to determine what a dog’s nose knows about people with diabetes and severe hypoglycemia
30 July 2012 | By Eli Lilly and Company
Data to explore future treatment possibilities for people with type 1 diabetes...
Afinitor® approved by European Commission to treat patients with the most common form of advanced breast cancer
30 July 2012 | By Novartis
The EC has approved Afinitor®...
Abbott’s HUMIRA® (adalimumab) approved in Europe for treatment of non-radiographic axial spondyloarthritis
30 July 2012 | By Abbott
The European Commission has approved HUMIRA®...
GSK announces acquisition of 79% of Human Genome Sciences shares
30 July 2012 | By GlaxoSmithKline
GSK announced the results of its initial tender offer for all outstanding shares of HGS...
Pooled analysis showed Onglyza® provided improvements in key measures of blood sugar control
30 July 2012 | By Bristol-Myers Squibb
Bristol-Myers Squibb and AstraZeneca announced the results of analyses...
Roche reports second positive study of RoACTEMRA given to patients with rheumatoid arthritis
27 July 2012 | By Roche
Data will be submitted to health authorities globally...
